Surgical and pharmacological animal models used in drug metabolism and pharmacokinetics

References

• Angus DW, Baker JA, Mason R, Martin IJ. (2008). The potential influence of CO2, as an agent for euthanasia, on the pharmacokinetics of basic compounds in rodents. Drug Metab Dispos 36:375–379.
   Google Scholar
• Bacha P, Forte S, Kassam N, Thomas J, Akiyoshi D, Waters C, Nichols J, Rosenblum M. (1990). Pharmacokinetics of the recombinant fusion protein DAB486IL-2 in animal models. Cancer Chemother Pharmacol 26:409–414.
   Google Scholar
• Bachir-Cherif D, Blum D, Braendli-Baiocco A, Chaput E, Pacheco GCD, Flint N, Haiker M, Hoflack J, Justies N, Neff R, Starke V, Steiner G, Tournillac CA, Singer T, Ubeaud-Séquier G, Schuler F. (2011). Character-ization of post-surgical alterations in the bile duct-cannulated rat. Xenobiotica 41:701–711.
   Web of Science ®Google Scholar
• Balani SK, Li P, Nguyen J, Cardoza K, Zeng H, Mu DX, Wu JT, Gan LS, Lee FW. (2004). Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling. Drug Metab Dispos 32:1092–1095.
   PubMed Web of Science ®Google Scholar
• Balani SK, Zhu T, Yang TJ, Liu Z, He B, Lee FW. (2002). Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys. Drug Metab Dispos 30:1059–1062.
   PubMed Web of Science ®Google Scholar
• Bessems M, ‘t Hart NA, Tolba R, Doorschodt BM, Leuvenink HG, Ploeg RJ, Minor T, van Gulik TM. (2006). The isolated perfused rat liver: Standardization of a time-honoured model. Lab Anim 40:236–246.
   PubMed Web of Science ®Google Scholar
• Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, van Bladeren PJ, Walther B. (2000). Determining the best animal model for human cytochrome P450 activities: A comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30:1131–1152.
   PubMed Web of Science ®Google Scholar
• Boyd M, Risovic V, Jull P, Choo E, Wasan KM. (2004). A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: Cannulation of the mesenteric and thoracic lymph ducts within the rat. J Pharmacol Toxicol Methods 49:115–120.
   PubMedGoogle Scholar
• Charman WN, Stella VJ. (1991). Transport of lipophilic molecules by the intestinal lymphatic system. Advanced Drug Delivery Reviews 7:1–14.
   Web of Science ®Google Scholar
• Chirino AJ, Ary ML, Marshall SA. (2004). Minimizing the immunogenicity of protein therapeutics. Drug Discov Today 9:82–90.
   PubMed Web of Science ®Google Scholar
• Cui N, Friend DR, Fedorak RN. (1994). A budesonide prodrug accelerates treatment of colitis in rats. Gut 35:1439–1446.
   PubMed Web of Science ®Google Scholar
• Cunningham F, Jonathan E, Peter L. (2010) Comparative and Veterinary Pharmacology. Berlin Heidelberg: Springer-Verlag.
   Google Scholar
• Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, Vidal JM, Van De Vorstenbosch C. (2001). A good practice guide to the administration of substances and removal of blood, including routes and volumes. Journal of Applied Toxicology 21:15–23.
   PubMed Web of Science ®Google Scholar
• Edwards GA, Porter CJ, Caliph SM, Khoo SM, Charman WN. (2001). Animal models for the study of intestinal lymphatic drug transport. Advanced Drug Delivery Reviews 50:45–60.
   PubMed Web of Science ®Google Scholar
• Fagerholm U, Nilsson D, Knutson L, Lennernäs H. (1999). Jejunal permeability in humans in vivo and rats in situ: Investigation of molecular size selectivity and solvent drag. Acta Physiol Scand 165:315–324.
   PubMedGoogle Scholar
• Faure L, Vignand P, Raynard A, Pasello-Legrand F, Descotes J. (2006). Evaluation of a surgical procedure to measure drug biliary excretion of rats in regulatory safety studies. Fundamental & Clinical Pharmacology 20:587–593.
   Google Scholar
• FELASA. (1994). Pain and distress in laboratory rodents and lagomorphs. Report of the Federation of European Laboratory Animal Science Associations (FELASA) working group on pain and distress accepted by the FELASA Board of Management November 1992. Lab Anim 28:97–112.
   Google Scholar
• Feldman BF, Zinkl JG, Jain NC. eds. (2000). Schalm’s veterinary hematology. 5th Edn. Baltimore, MD: Lippincott Williams & Wilkins.
   Google Scholar
• Flecknell PA. (1993). Anaesthesia of animals for biomedical research. Br J Anaesth 71:885–894.
   PubMed Web of Science ®Google Scholar
• Friend DR, Chang GW. (1984). A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. J Med Chem 27:261–266.
   PubMed Web of Science ®Google Scholar
• Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L; International Transporter Consortium. (2010). Membrane transporters in drug development. Nat Rev Drug Discov 9:215–236.
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. (2003). Role of gene knockout and transgenic mice in the study of xenobiotic metabolism. Drug Metab Rev 35:319–335.
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Pastan I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427.
   PubMed Web of Science ®Google Scholar
• Guiney WJ, Beaumont C, Thomas SR. (2010). Use of the entero-test, a novel approach for the noninvasive capture of biliary metabolites in dogs. Drug Metab Dispos 38:851–856.
   PubMed Web of Science ®Google Scholar
• Heimann M, Roth DR, Ledieu D, Pfister R, Classen W. (2010). Sublingual and submandibular blood collection in mice: A comparison of effects on body weight, food consumption and tissue damage. Laboratory Animals 44:352–358.
   Google Scholar
• Hopkinson DN, Odom NJ, Eloakley RM, Au J, Hooper TL. (1995). A technique for studying the function of an isolated, perfused and ventilated lung in a rat model. Lab Anim 29:96–101.
   Google Scholar
• Hull RM. (1995). Guideline limit volumes for dosing animals in the preclinical stage of safety evaluation. Human and Experimental Toxicology 14:305–307.
   PubMed Web of Science ®Google Scholar
• Kissinger JT, Garver EM, Institute For Human Gene Therapy University Of Pennsylvania Philadelphia PA 19104 Jonathan D Schantz MA, Schantz JD, Coatney RW, Meunier LD. (1998). A new method to collect bile and access the duodenum in conscious dogs. Contemp Top Lab Anim Sci 37:89–93.
   Google Scholar
• Kunta JR, Perry BA, Sutyak JP, Sinko PJ. (2001). Development of a novel intestinal and vascular access port (IVAP) rabbit model to study regiospecific oral absorption pharmacokinetics. Comp Med 51:349–356.
   Google Scholar
• Kuntner C, Bankstahl JP, Bankstahl M, Stanek J, Wanek T, Stundner G, Karch R, Brauner R, Meier M, Ding X, Muller M, Loscher W, Langer O. (2010). Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PET. Eur J Nucl Med Mol Imaging 37:942–953.
   PubMed Web of Science ®Google Scholar
• Kurien BT, Everds NE, Scofield RH. (2004). Experimental animal urine collection: A review. Laboratory Animals 38:333–361.
   PubMed Web of Science ®Google Scholar
• Kwan Y. (2001). Handbook of essential pharmacokinetics, pharmacodynamics, and drug metabolism for industrial scientists. New York: Kluwer Academic.
   Google Scholar
• Leak LV. (1976). The structure of lymphatic capillaries in lymph formation. Fed Proc 35:1863–1871.
   PubMedGoogle Scholar
• Lin JH. (1995). Species similarities and differences in pharmacokinetics. Drug Metab Dispos 23:1008–1021.
   PubMed Web of Science ®Google Scholar
• Lin JH, Chiba M, Balani SK, Chen IW, Kwei GY, Vastag KJ, Nishime JA. (1996). Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Drug Metab Dispos 24:1111–1120.
   PubMed Web of Science ®Google Scholar
• Linder CD, Renaud NA, Hutzler JM. (2009). Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator? Drug Metab Dispos 37:10–13.
   PubMed Web of Science ®Google Scholar
• Lu C, Li AP. (2001). Species comparison in P450 induction: Effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem Biol Interact 134:271–281.
   PubMed Web of Science ®Google Scholar
• Meunier LD, Kissinger JT, Marcello J, Nichols AJ, Smith PL. (1993). A chronic access port model for direct delivery of drugs into the intestine of conscious dogs. Lab Anim Sci 43:466–470.
   Google Scholar
• Obach RS. (1999). Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350–1359.
   PubMed Web of Science ®Google Scholar
• Ose A, Kusuhara H, Yamatsugu K, Kanai M, Shibasaki M, Fujita T, Yamamoto A, Sugiyama Y. (2008). P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier. Drug Metab Dispos 36:427–434.
   PubMed Web of Science ®Google Scholar
• Paulson SK, Engel L, Reitz B, Bolten S, Burton EG, Maziasz TJ, Yan B, Schoenhard GL. (1999). Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab Dispos 27:1133–1142.
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Turpeinen M. (2007). In vitro-in vivo extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica 37:1066–1089.
   PubMed Web of Science ®Google Scholar
• Remie RJ, Rensema W, Havinga R, Kuipers F. (1991). The permanent bile fistula rat model. Progress in Pharmacology and Clinical Pharmacology 8:127–145.
   Google Scholar
• Rowland M, Emmons GT. (2010). Use of dried blood spots in drug development: Pharmacokinetic considerations. AAPS J 12:290–293.
   PubMed Web of Science ®Google Scholar
• Shenton JM, Chen J, Uetrecht JP. (2004). Animal models of idiosyncratic drug reactions. Chem Biol Interact 150:53–70.
   PubMed Web of Science ®Google Scholar
• Shou M, Lu W, Kari PH, Xiang C, Liang Y, Lu P, Cui D, Emary WB, Michel KB, Adelsberger JK, Brunner JE, Rodrigues AD. (2005). Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey. Eur J Pharm Sci 26:151–161.
   PubMed Web of Science ®Google Scholar
• Simpkins JW, Smulkowski M, Dixon R, Tuttle R. (1988). Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates. J Pharmacol Exp Ther 244:195–205.
   PubMed Web of Science ®Google Scholar
• Stiborová M, Arlt VM, Henderson CJ, Wolf CR, Kotrbová V, Moserová M, Hudecek J, Phillips DH, Frei E. (2008). Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:cytochrome P450 reductase null mouse. Toxicol Appl Pharmacol 226:318–327.
   PubMed Web of Science ®Google Scholar
• Strelevitz TJ, Foti RS, Fisher MB. (2006). In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: Varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance. J Pharm Sci 95:1334–1341.
   PubMed Web of Science ®Google Scholar
• Taft DR. (2004). The isolated perfused rat kidney model: A useful tool for drug discovery and development. Curr Drug Discov Technol 1:97–111.
   PubMedGoogle Scholar
• Tang W, Stearns RA, Chen Q, Bleasby K, Teffera Y, Colletti A, Hafey M, Evers R, Dean DC, Magriotis PA, Lanza TJ, Lin LS, Hagmann WK, Baillie TA. (2008). Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N -sulfonylated dipeptide VLA-4 antagonist in rats. Xenobiotica 38:223–237.
   PubMed Web of Science ®Google Scholar
• Tønsberg H, Holm R, Bjerregaard TG, Boll JB, Jacobsen J, Müllertz A. (2010). An updated and simplified method for bile duct cannulation of rats. Lab Anim 44:373–376.
   Google Scholar
• Torjman MC, Joseph JI, Munsick C, Morishita M, Grunwald Z. (2005). Effects of isoflurane on gastrointestinal motility after brief exposure in rats. Int J Pharm 294:65–71.
   PubMedGoogle Scholar
• Toutain PL, Ferran A, Bousquet-Mélou A. (2010). Species differences in pharmacokinetics and pharmacodynamics. Handbook of Experimental Pharmacology 199:19–48.
   PubMedGoogle Scholar
• Turpeinen M, Ghiciuc C, Opritoui M, Tursas L, Pelkonen O, Pasanen M. (2007). Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: A comparative study in vitro. Xenobiotica 37:1367–1377.
   PubMed Web of Science ®Google Scholar
• Urban E, Zingery AA. (1981). A simple method of cannulating the portal vein and obtaining multiple blood samples in the rat. Experientia 37:1036–1037.
   Google Scholar
• van De Waterbeemd H, Smith DA, Beaumont K, Walker DK. (2001). Property-based design: Optimization of drug absorption and pharmacokinetics. J Med Chem 44:1313–1333.
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, Wagenaar E, van der Kruijssen CM, van Waterschoot RA, Smit JW, Song JY, van der Valk MA, van Tellingen O, van der Hoorn JW, Rosing H, Beijnen JH, Schinkel AH. (2007). Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. J Clin Invest 117:3583–3592.
   PubMed Web of Science ®Google Scholar
• van Wijk H, Donachie P, Mann DL, McMahon H, Robb D. (2001). A novel bile duct cannulation method with tail cuff exteriorization allowing continuous intravenous infusion and enterohepatic recirculation in the unrestrained rat. Lab Anim 35:325–333.
   PubMed Web of Science ®Google Scholar
• Ward KW, Azzarano LM. (2004). Preclinical pharmacokinetic properties of the P-glycoprotein inhibitor GF120918A (HCL salt of GF120918, 9,10-dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the mouse, rat, dog, and monkey. J Pharmacol Exp Ther 310:703–709.
   PubMed Web of Science ®Google Scholar
• Yuki K, Astrof NS, Bracken C, Soriano SG, Shimaoka M. (2010). Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology 113:600–609.
   PubMed Web of Science ®Google Scholar
• Yuki K, Astrof NS, Bracken C, Yoo R, Silkworth W, Soriano SG, Shimaoka M. (2008). The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J. 22:4109–4116.
   PubMed Web of Science ®Google Scholar